Interview with Dr Altino de Almeida – Part 2
This is the second part of our interview with the esteemed Dr Christina Altino de Almeida. As she herself contracted COVID-19, was treated and is
This is the second part of our interview with the esteemed Dr Christina Altino de Almeida. As she herself contracted COVID-19, was treated and is
This Wednesday June 24, Dr Didier Raoult, the esteemed professor of infectious diseases at the IHU-Marseille, presented a shock testimony at a special commission, in
This interview features one of the most prominent medical doctors in the current COVID-19 crisis in Brazil. The esteemed Dr Cristiana Altino de Almeida, who
During this COVID-19 crisis, Canada has been very proactive in preventing hydroxychloroquine treatments. In March, after a short wave of hoarding by medical professionals in
The much anticipated research on 3,737 COVID-19 patients by Professor Raoult and his team was published this June 25th, as a pre-proof, in the journal
With the peak of the COVID-19 crisis behind us, for many of us, we talk to more people, and obviously, a main topic remains the
Professor Perronne’s book “Is there a mistake they did not do? COVID-19: the sacred union of incompetence and arrogance” continues to make waves in France,
These are notes relating to a video of a recent TV programme in Brazil about COVID-19 and hydroxychloroquine-based treatments. They were put together by a
“This is your Darkest Hour, Boris: let’s have some real leadership. Without that, God help us all.” While the #OxfordGate #RecoveryGate #CovidPapers story is still
The governmental research institute of the Canadian province of Quebec, the INESSS, published on June 15 an update to its position on chloroquine / hydroxychloroquine.
At a media conference this Tuesday, COVID-19 survivor and UK prime minister Boris Johnson announced “the biggest breakthrough yet” regarding therapies for the coronavirus. THIS
“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result,” said Peter Horby, Professor of Emerging Infectious